Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IFITM3 pseudogene 9 is a human pseudogene derived from the interferon-induced transmembrane protein 3 (IFITM3) gene[5]. Unlike the functional IFITM3 gene, which encodes a well-characterized broad-spectrum antiviral protein, IFITM3P9 is a non-protein-coding locus with no confirmed translation product. Recent gene expression studies have observed that some IFITM3-related pseudogenes—including IFITM3P9—may be involved in the regulation of cellular antiviral responses, potentially through long non-coding RNA mechanisms, but direct evidence of function is lacking[5]. IFITM3P9 has been identified in interferon-stimulated gene signatures in single-cell immune profiling from viral infection patients, suggesting its transcription may be induced during infection; however, no direct biological, pathological, or therapeutic relevance has been established[5].
None established
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on IFITM3 pseudogene 9 (IFITM3P9).